In cells latently infected with Epstein-Barr virus, the switch from latency to productive infection is linked to the expression of two Epstein-Barr virus transcription factors called EB1 and R. R is an enhancer factor, and an R-responsive element (RRE) has been identified in the BMLF1 promoter. In this study, we have used bidirectional deletion mutagenesis to delineate the BMLF1 RRE (RRE-M) to a 44-bp sequence. We also show that R expressed from a recombinant vaccinia virus protects RRE-M against digestion by DNase I. Using mobility shift assays and dimethyl sulfate interferences, we have characterized the contact points between in vitrotranslated R and the DNA. R binds in vitro to one site by simultaneously contacting two sequences within the site, which are separated by 8 bp: 5'-catGTCCCtctatcatGGCGCagac-3'. Site-directed mutagenesis of this sequence completely impired the binding of R in vitro and rendered the BMLF1 promoter nonresponsive to R. The results suggest that the R-inducible BMLF1 enhancer is composed of a single R-binding site, called RRE-M. The human herpesvirus Epstein-Barr virus (EBV) infects and immortalizes peripheral B lymphocytes, resulting in the establishment of a latent infection. In such infected B cells, the entire EBV genome is maintained predominantly as a plasmid, and its expression is reduced to a few genes (for a review, see reference 24). The latent EBV genome is spontaneously activated in particular cell lines, in which between 0.5 and 5% of the cells produce viruses. It can also be activated by various chemical agents, including the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (29) . In both cases, the activation seems to be linked to the expression of two EBV-encoded transactivators of early gene promoters, EB1 (also called ZEBRA, Z, BZLF1, or Zta) and R (also called Rta) (4-9, 12, 17, 19, 25, 27, 28). EB1 is encoded by the BZLF1 open reading frame and is expressed as a 1-kb mRNA (22) (Fig. 1) . It is related to the AP-1/ATF/ CREB/GCN4 family of transcription factors and interacts as an homodimer with many different DNA sequences (3, 11, 21) . R is encoded by the BRLF1 open reading frame and is expressed from 3-and 4-kb mRNAs generated by alternative splicing which express both EB1 and R (17, 22) (Fig. 1) . R seems to be a factor that can act at distances over thousands of base pairs, and several R-responsive elements (RRE) have been identified (4, 9, 19). One (RRE-DR) is part of the DR/DL promoter (4, 9) and overlaps with the enhancer of the EBV origins of replication active only during the lytic cycle and called ORIlyt (16). R binds independently in vitro to two sites within RRE-DR (14) (RRE-DR1 and RRE-DR2). Each binding site covers about 18 bp, where R is thought to simultaneously contact two core sequences separated by 5 or 7 bp (14). A second RRE (RRE-M), localized in the BMLF1 promoter PM, controls the expression of two mRNAs coding for a factor acting at a posttranscriptional level (2, 19, 20) (Fig. 1) In this report, we show that in vitro R binds to, and activates transcription from, a unique site covering 19 bp in the BMLF1 promoter. In this site, called 19, 20) , R interacts with the DNA by simultaneously contacting two core sequences separated by 8 bp. RRE-M has some homologies with RRE-DR1 and RRE-DR2, but these three R-binding sites are imperfectly conserved. Site-directed mutagenesis in this R-binding sequence completely impaired induction by R of the BMLF1 promoter.
The human herpesvirus Epstein-Barr virus (EBV) infects and immortalizes peripheral B lymphocytes, resulting in the establishment of a latent infection. In such infected B cells, the entire EBV genome is maintained predominantly as a plasmid, and its expression is reduced to a few genes (for a review, see reference 24) . The latent EBV genome is spontaneously activated in particular cell lines, in which between 0.5 and 5% of the cells produce viruses. It can also be activated by various chemical agents, including the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (29) . In both cases, the activation seems to be linked to the expression of two EBV-encoded transactivators of early gene promoters, EB1 (also called ZEBRA, Z, BZLF1, or Zta) and R (also called Rta) (4-9, 12, 17, 19, 25, 27, 28) . EB1 is encoded by the BZLF1 open reading frame and is expressed as a 1-kb mRNA (22) (Fig. 1) . It is related to the AP-1/ATF/ CREB/GCN4 family of transcription factors and interacts as an homodimer with many different DNA sequences (3, 11, 21) . R is encoded by the BRLF1 open reading frame and is expressed from 3-and 4-kb mRNAs generated by alternative splicing which express both EB1 and R (17, 22) (Fig. 1) . R seems to be a factor that can act at distances over thousands of base pairs, and several R-responsive elements (RRE) have been identified (4, 9, 19) . One (RRE-DR) is part of the DR/DL promoter (4, 9) and overlaps with the enhancer of the EBV origins of replication active only during the lytic cycle and called ORIlyt (16) . R binds independently in vitro to two sites within RRE-DR (14) (RRE-DR1 and RRE-DR2). Each binding site covers about 18 bp, where R is thought to simultaneously contact two core sequences separated by 5 or 7 bp (14) . A second RRE (RRE-M), localized in the BMLF1 promoter PM, controls the expression of two mRNAs coding for a factor acting at a posttranscriptional level (2, 19, 20) (Fig. 1 In this report, we show that in vitro R binds to, and activates transcription from, a unique site covering 19 bp in the BMLF1 promoter. In this site, called RRE-M (2, 19, 20) , R interacts with the DNA by simultaneously contacting two core sequences separated by 8 bp. RRE-M has some homologies with RRE-DR1 and RRE-DR2, but these three R-binding sites are imperfectly conserved. Site-directed mutagenesis in this R-binding sequence completely impaired induction by R of the BMLF1 promoter.
MATERIALS AND METHODS
Cloned DNA templates. The R expression vector has been described elsewhere (22) . Plasmid pM13 and mutants with deletions extending in the 5'-to-3' direction from the 5' side of the BMLF1 promoter were constructed as previously described (2) . Mutants with deletions extending in the 3'-to-5' direction were made as follows. Plasmid pM13 was opened at position -299 with PvuII ( Fig. 2A) and digested for various times with Bal 31 exonuclease. Selected DNAs were treated with T4 DNA polymerase and redigested with EcoRI. These DNA fragments were then ligated to plasmid pM13 cut by PvuII and EcoRI. Plasmid pSV2P (15) (Fig. 3A) .
Production of R and mutant proteins in vitro. The BRLF1 ORF was cloned in plasmid pSPT19 (Boehringer Mannheim). Cloned inserts within the polylinker region were transcribed from theSP6 promoters. The RNA obtained was used to program protein synthesis in messenger-dependent rabbit reticulocyte lysates (Promega), using L-[14C]leucine. DNase I footprints. Footprint experiments were done by using EBV BMLF1 enhancer probes derived from plasmid pM13, 5 ' labeled with 32P either at position -299 on the coding strand (probe pGM13C) or at position -494 on the noncoding strand (probe pGM13NC) (Fig. 4A) . The experimentalprocedure was as previously described (14) .
Electrophoretic mobility shift assay (EMSA (13) . Cells were mixed with the appropriate DNA(s), and the DNAs were in the same topological state as assayed by agarose gel electrophoresis. Usually 15 ,ug of DNA was used per 100-mm dish as follows: 0.5 ,ug of R-expressing vector, 5,ug of reporter promoters, pSVO when required, 0.5 p.g of pSV2,3 as an internal control, and pUC19 up to 15,ug. RNA extraction and Si nuclease mapping. Transfected cells were lysed with Nonidet P-40 as described elsewhere (18) . Nuclei were pelleted, and RNA was phenol extracted from the cytoplasmic fraction. Then 10 to 40 ,ug of total cytoplasmic RNA was hybridized'overnight at 30°C in 50% formamide-0.3 M NaCI-0.01 M Tris-HCl (pH 7.4) to 5' 32p labeled synthetic single-stranded DNA probes ( Fig. 2A) . The hybrids we're digested for 2 h at 20°C with 5 U ofS1 nuclease per 10 ,ug of RNA. The size of the S1-protected DNA fragment was analyzed on 8% (wt/vol) acrylamide-8.3 M urea gels. Quantification was made by cutting the specific S1-protected bands out of the gel and counting the radioactivity. The results were corrected as follows: (i) according to the efficiency of transfection as evaluated by counting the radioactivity present in S1-protected probes corresponding to specific SV40 early RNA expressed from plasmid pSV2, and (ii) according to the activities of the different constructions in the absence of R.
RESULTS
The BMLF1 RRE is contained within 44 bp. The BMLF1 promoter is strongly activated by R (2, 19, 20) . We have previously shown, using deletion mutants extending in the 5'-to-3' direction from the 5' side of the BMLF1 promoter ( Fig. 2A , mutants M13 to M10), that R-induced transcriptional activation is impaired by deletion of sequences located between positions -400 and -389 before the major initiation site (2). This is seen at both low and high R concentrations, indicating that there is no residual R-inducible activity after deletion of sequences from -400 to -389 (Fig. 2B ). The increase in R-induced activity of the BMLF1 promoter followed by transfection of increasing amounts of R-expressing vector is likely to be due to increasing amounts of the R protein. In effect, as evaluated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and immunoblotting, VOL. 66, 1992 48 GRUFFAT ET AL. R, and this effect could not be compensated for by increasing the amount of R expressed (Fig. 2C, lanes 13 to 16) . In conclusion, it would seem that there is at least one RRE within or overlapping with the sequences located between positions -400 and -356 in the BMLF1 promoter. Plasmid pSV2p, expressing a chimeric SV40-p-globin RNA under the control of the SV40 early promoter-enhancer sequences, was cotransfected as a control for transfection efficiency (Fig. 2B and C, labeled SV ). An equal amount of specifically initiated RNA was found in every transfection, indicating that the results described above could be compared.
R constitutively produced in HeLa cells infected by a recombinant vaccinia virus protects the BMLF1 RRE against DNase I digestion. Having shown that at least one RRE was located between positions -400 and -356, we wanted to determine whether R binds to this region and where. HeLa and R-recombinant vaccinia virus-infected HeLa WCEs were used in conjunction with 5'-end-labeled doublestranded DNA probes covering the RRE to determine the sequence-specific DNA-binding properties of R by DNase I footprinting. The vaccinia virus-infected HeLa WCE (Fig.  3B , HeLavvR WCE) contains a polypeptide recognized by a rabbit anti-R polyclonal antibody that is not detected in noninfected HeLa cells (Fig. 3B , HeLa WCE). Heparin Ultrogel agarose chromatography was used to partially purify the R protein from the WCEs. A typical elution profile is presented in Fig. 3A (Fig. 3B) .
One probe was 5' end labeled close to position -299 and called pGM13NC, and the other probe was 5' end labeled on the opposite strand close to position -494 and called pGM13C (Fig. 4A) . No clear footprint was detected on probe pGM13C with the HeLa WCE heparin fraction (Fig. 4B,  lanes 3 and 4) compared with the DNase I digestion pattern obtained with the probe alone (Fig. 4B, lane 2) . However, in the presence of the HeLavvR heparin fraction (Fig. 4B , lanes to 7), a change in the digestion pattern occurred, with the appearance of several DNase-hypersensitive sites, designated a through g, and of a DNase I-protected area called region I (-365 to -393), located between DNase I-hypersensitive sites b and c. These observations suggest that R binds directly to this region.
DNase footprints were also performed on probe pGM13NC (Fig. 4C) . Again, the DNase digestion pattern in the presence of the HeLa WCE heparin fraction (Fig. 4C,  lanes 3 and 4) was not notably altered compared with the digestion pattern observed with the probe alone (Fig. 4C,  lane 2) . However, R expressed from the recombinant vaccinia virus modified the digestion pattern, with the induction of seven DNase I-hypersensitive sites and the appearance of a DNase I-protected area (region II, -349 to -414), located between the hypersensitive sites 1 and 5 (Fig. 4C, lanes 5 to  7) . These results suggest that R interacts directly with RRE-M (-400 to -356), mediating the R activation in a transient expression assay, as defined by deletion mutagenesis (Fig. 1B) .
R binds directly to the BMLF1 RRE in vitro. To determine further whether R directly binds to the BMLF1 RRE, we performed EMSA using the in vitro-translated R protein in conjunction with three double-stranded DNA fragments overlapping region I and region II, called M16e, Ml5e, and M14e (Fig. 5A ). RNAs transcribed from the SP6 promoter located upstream from the R gene were used to program protein synthesis in messenger-dependent rabbit reticulocyte lysates. In these lysates, a 90-kDa [14C]leucine-labeled polypeptide was detected and was immunoprecipitated by anti-R antibody (not shown). We also made use, as competitors, of the double-stranded oligonucleotide called BO (Fig.  5A) , which corresponds to one of the two R-binding sites in the ORIlyt/DR promoter (RRE-DR1 [14] ), and of a mutated version called BO* which does not bind in vitro-translated R (14) .
As judged by EMSA and competitions, specific binding of R was observed to 32P-radiolabeled probes M16e and M15e, but no complexes formed detectably on probe M14e (Fig.  SB) . The in vitro-translated R bound with a high affinity to M16e (Fig. 5B, lane 2) and to M15e (Fig. 5B, lane 6 ) but poorly to M14e (Fig. 5B, lane 10) . Specific binding was abolished by a 400-fold molar excess of unlabeled BO (Fig.  5B, lanes 3, 7, and 11 ), but unlabeled BO* did not detectably compete for the binding of R (Fig. 5B, lanes 4, 8, and 12) . These results, together with those of the deletion mutagenesis studies and the DNase I footprinting experiments, suggest that there is an R-binding site overlapping probes M15e and M14e.
R binds in vitro to a single site in the BMLF1 RRE. Since in vitro-translated R bound specifically to probe M16e (Fig. 5B,  lanes 1 to 4) , the contact points of R with a DNA fragment containing these sequences (probe M16E; Fig. 6A) were probed chemically by modification of the DNA with DMS (methylation interference analysis). After partial methylation at purine residues, the modified probe was used in the gel retardation assay. Free and bound probe DNA was recovered and subjected to chemical cleavage at methylation sites, and the products were resolved by gel electrophoresis under denaturing conditions. On both the coding and the noncoding strands of probe M16E, strong interferences were detected on guanine residues in the sequences 5'-GGCGC-3' and 5'-GTCCC-3' (Fig. 6B) . Such strong interferences suggest that R simultaneously contacts both sequences rather than binding to them separately. The results of the methylation interferences (summarized in Fig. 6A ) suggest that R binds to a site consisting of two regions separated by 8 Fig. 2A . Closed rectangles over and under the sequence of probe BO show the contact points between R and this DNA probe as determined by DMS interferences (14) . Accordingly, some of these contact points have been mutated and are marked by asterisks in probe BO*. (B) In vitro-translated R was incubated with probes M16e (lanes 1 to 4) , Ml5e (lanes 5 to 8), and M14e (lanes 9 to 12) and with DNA competitors as indicated at the top: /, no competitor added; L, lysate translated with brome mosaic virus RNA. DNA competitors were added at a mass ratio of 400. Free (F) and bound (B) DNA probes are indicated at the left. NS, nonspecific complexes.
The R-binding site called RRE-M mediates the R-induced activity of the BMLF1 promoter. To further evaluate the contribution of the R-binding site in the R-induced activity of the BMLF1 promoter, we mutated RRE-M (Fig. 7A, mutant M13m). This mutation impaired totally the binding of R to the isolated RRE-M in vitro (not shown). The mutated promoter (M13m) and the wild-type promoter (Fig. 7A, M13) were transfected into HeLa cells either alone or with 0.5 ,ug of R expression vector, and their transcriptional activity was evaluated by quantitative Si analysis. Representative results are shown in Fig. 7B . As expected, the activity of the wild-type BMLF1 promoter in mutant M13 (Fig. 7B, lane 1 was activated by R (Fig. 7B, lane 2) , but when six base pairs were changed in RRE-M, the R-induced activation was strongly impaired (Fig. 7B, lanes 3 and 4) . Plasmid pSV23, expressing a chimeric SV40-p-globin RNA under the control of the SV40 early promoter-enhancer sequences, was cotransfected as a control for transfection efficiency (Fig. 7B (14) , RRE-DR1 (5'-CCTGTGC CTTGTCCCGTGGACAATGTC-3') and RRE-DR2 (5'-CAA TGTCCCTCCAGCGTGGTGGCTG-3').
R seems to contact directly and simultaneously the regions delineated by bold letters, and this proposal is made on the following observations. First, mutagenesis in one or the other of these two regions impairs the binding of R in vitro and impairs transcriptional activation by R mediated by these sites in transient expression assays. Second, methylation of the purine residues in the binding site induced a 100% binding interference, demonstrating that the two regions are not individual binding sites. This conclusion was confirmed by mixing an extract containing the R protein with an extract containing a truncated form of R and then adding to this mixture a radioactive probe containing an R-binding site and analyzing the protein-DNA complexes formed by EMSA. In this situation, besides the complexes of low and high mobility corresponding to the wild-type and truncated protein-DNA complexes, respectively, no complex of intermediate mobility corresponding to the binding of one R protein and one truncated mutant appeared (23) .
The three sites characterized can be aligned and share some sequence homologies (Fig. 6C ), but these homologies do not as yet allow us to propose a consensus. There are, however, several interesting structural features in the three RREs. First, the sequences which are thought to be directly and simultaneously contacted by R (letters in bold) are separated by 5 to 8 bp and are not therefore on the same side of the DNA double helix. Second, the 5' side of the RREs, GTG/CCC, is rather conserved, although the 3' side is not. Third, the three R-binding sites are imperfectly symmetric but R interacts in vitro as an homodimer with the three RREs, and the dimerization region and the DNA-interaction region overlap a region of 280 amino acids (23) . None of these regions have obvious homologies with already described dimerization and DNA-binding domains, suggesting that the interaction of R with DNA is mediated by novel protein structures.
Finally, mutation in the BMLF1 promoter of the R-binding site completely abolished the activity of the R-inducible enhancer. This finding also suggests that the R-responsive enhancer in the BMLF1 promoter contains a single R-binding site. This conclusion was also confirmed by the deletion mutagenesis, by the DNase footprints, and by the DMS interferences studies.
However, there could be two R-binding sites, as in the DR promoter (14) , but R would in this case bind cooperatively to the second site and only when the stronger adjacent site (RRE-M) is occupied. To test this possibility, we made shift-up probes containing the BMLF1 promoter sequences from positions -299 to -494 and tested the binding of increasing amounts of R either translated in vitro or produced by the recombinant vaccinia virus. In both cases, only one type of complex formed on this probe, at low and high protein concentrations, indicating that there is no cooperative binding to a second R-binding site in the BMLF1 promoter on this probe (not shown).
In conclusion, the BMLF1 R-responsive enhancer seems to contain a single R-binding site, only partially homologous to the other binding sites identified in the DR promoter (14) .
